Literature DB >> 10581259

A single amino acid alteration (101L) introduced into murine PrP dramatically alters incubation time of transmissible spongiform encephalopathy.

J C Manson1, E Jamieson, H Baybutt, N L Tuzi, R Barron, I McConnell, R Somerville, J Ironside, R Will, M S Sy, D W Melton, J Hope, C Bostock.   

Abstract

A mutation equivalent to P102L in the human PrP gene, associated with Gerstmann-Straussler syndrome (GSS), has been introduced into the murine PrP gene by gene targeting. Mice homozygous for this mutation (101LL) showed no spontaneous transmissible spongiform encephalopathy (TSE) disease, but had incubation times dramatically different from wild-type mice following inoculation with different TSE sources. Inoculation with GSS produced disease in 101LL mice in 288 days. Disease was transmitted from these mice to both wild-type (226 days) and 101LL mice (148 days). In contrast, 101LL mice infected with ME7 had prolonged incubation times (338 days) compared with wild-type mice (161 days). The 101L mutation does not, therefore, produce any spontaneous genetic disease in mice but significantly alters the incubation time of TSE infection. Additionally, a rapid TSE transmission was demonstrated despite extremely low levels of disease-associated PrP.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10581259      PMCID: PMC1171748          DOI: 10.1093/emboj/18.23.6855

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  76 in total

1.  Grand ideas floating freely. Conference on the new prion biology: basic science, diagnosis and therapy.

Authors:  Bruce Chesebro
Journal:  EMBO Rep       Date:  2002-12       Impact factor: 8.807

Review 2.  Transgenesis applied to transmissible spongiform encephalopathies.

Authors:  Jean-Luc Vilotte; Hubert Laude
Journal:  Transgenic Res       Date:  2002-12       Impact factor: 2.788

3.  Immunodetection of disease-associated mutant PrP, which accelerates disease in GSS transgenic mice.

Authors:  Karah E Nazor; Franziska Kuhn; Tanya Seward; Mike Green; Daniel Zwald; Mario Pürro; Jaqueline Schmid; Karin Biffiger; Aisling M Power; Bruno Oesch; Alex J Raeber; Glenn C Telling
Journal:  EMBO J       Date:  2005-06-16       Impact factor: 11.598

4.  Highly sensitive, quantitative cell-based assay for prions adsorbed to solid surfaces.

Authors:  Julie Ann Edgeworth; Graham S Jackson; Anthony R Clarke; Charles Weissmann; John Collinge
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-09       Impact factor: 11.205

5.  Prion Protein Prolines 102 and 105 and the Surrounding Lysine Cluster Impede Amyloid Formation.

Authors:  Allison Kraus; Kelsie J Anson; Lynne D Raymond; Craig Martens; Bradley R Groveman; David W Dorward; Byron Caughey
Journal:  J Biol Chem       Date:  2015-07-14       Impact factor: 5.157

Review 6.  Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.

Authors:  Julie A Moreno; Glenn C Telling
Journal:  Methods Mol Biol       Date:  2017

7.  De novo generation of a transmissible spongiform encephalopathy by mouse transgenesis.

Authors:  Christina J Sigurdson; K Peter R Nilsson; Simone Hornemann; Mathias Heikenwalder; Giuseppe Manco; Petra Schwarz; David Ott; Thomas Rülicke; Pawel P Liberski; Christian Julius; Jeppe Falsig; Lothar Stitz; Kurt Wüthrich; Adriano Aguzzi
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-10       Impact factor: 11.205

8.  Prion propagation and toxicity occur in vitro with two-phase kinetics specific to strain and neuronal type.

Authors:  Samia Hannaoui; Layal Maatouk; Nicolas Privat; Etienne Levavasseur; Baptiste A Faucheux; Stéphane Haïk
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

9.  Brain delivery of AAV9 expressing an anti-PrP monovalent antibody delays prion disease in mice.

Authors:  Fabio Moda; Chiara Vimercati; Ilaria Campagnani; Margherita Ruggerone; Giorgio Giaccone; Michela Morbin; Lorena Zentilin; Mauro Giacca; Ileana Zucca; Giuseppe Legname; Fabrizio Tagliavini
Journal:  Prion       Date:  2012-07-30       Impact factor: 3.931

10.  Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteins.

Authors:  Emmanuel A Asante; Ian Gowland; Andrew Grimshaw; Jacqueline M Linehan; Michelle Smidak; Richard Houghton; Olufunmilayo Osiguwa; Andrew Tomlinson; Susan Joiner; Sebastian Brandner; Jonathan D F Wadsworth; John Collinge
Journal:  J Gen Virol       Date:  2009-03       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.